Custom antibody generation service
AltaBioscience provides a flexible custom monoclonal antibody generation service with options to suit customer requirements. With decades of experience within our team in creating monoclonal antibodies, we act as both a consultative and commercial presence.
Certified to ISO 9001, all aspects of the work are conducted in the UK. Peptide antigen synthesis can be provided by AltaBioscience or we can source the antigen for clients. Alternatively the antigen can be supplied by the client. Timescale for the complete program is 3-6 months depending on which aspects are chosen. The service is completely customisable depending on your requirements and we aim to fulfil your needs wherever possible.
Each project is split into 5 stages and the project can be terminated at the end of each stage if requested by the client.
We offer:
- Flexible monoclonal antibody generation package – choose the elements you require
- All aspects of work undertaken in the UK (compliant with UK ethical review standards)
- Options to terminate program at set stages – saving you time and money
- Ownership of all aspects of each project lines resides wholly with the client
Monoclonal antibody generation process
Our monoclonal process is identified by 5 phases. A typical monoclonal antibody project may yield up to 10 positive wells at the fusion screening stage and after cloning can deliver 2 or 3 stable monoclonal antibodies. However, the number of monoclonal antibodies generated in a project cannot be guaranteed. The project is charged per line of limiting dilution cloning to allow for ultimate flexibility and for greater numbers of candidates to be brought forward past the first stage. This gives a greater degree of flexibility in comparison to being priced by a set number of hybridomas.
Latest news

AltaBioscience – 50 years of Advancing Research in Life Science
This year, AltaBioscience celebrates its 50th anniversary. Originally founded in 1973, by Professor
John Fox and a team of protein scientists at the University of Birmingham, we take a look back over the last 50 years to see how we came to where we are today.

Meet us at the second annual Plant-Based Trends and Innovations Conference
We are pleased to announce that we will be exhibiting at the 2nd annual Plant-based Trends and Innovations Conference – Vegan, Health, Natural, Clean, taking place on 8th February 2023 in Central London.

Influenza virus peptides
Although there are ways to combat influenza viruses, they have evolved to mutate frequently in order to evade the host’s immune system.